EVIDENCE-BASEDAWAITING CLINICIAN REVIEW

Pertussis (whooping cough)

Pertussis, or whooping cough, is a highly contagious respiratory infection caused by Bordetella pertussis. It often begins like a mild cold and then evolves into prolonged coughing fits; infants may have apnea instead of a classic “whoop” and carry the greatest risk of hospitalization and death.

At a glance

Quick facts

{esc(snapshot_label)}
Cause
Bordetella pertussis
Spread
Respiratory droplets / close contact
Typical course
Catarrhal → paroxysmal → convalescent
Best diagnostic sample
Nasopharyngeal specimen
Treatment
Early macrolide antibiotics
Prevention
DTaP / Tdap + selected postexposure prophylaxis

Names & terminology

How this entity may be named or searched

Pertussis
Acute respiratory infection caused by Bordetella pertussis.
Whooping cough
Common name derived from the inspiratory “whoop” that can follow coughing paroxysms.
Catarrhal stage
Early phase with runny nose, mild cough and low fever; this is when antibiotics have the greatest potential to reduce severity.
Postexposure prophylaxis (PEP)
Antibiotics given to selected close contacts to reduce risk of severe disease and onward spread, especially around high-risk people.

Structured entity profile

Clinical profile

Condition data
NatureBordetella pertussisPertussis toxin and other bacterial factors injure respiratory epithelium and drive prolonged cough.
Typical settingRespiratory droplets / close contactHousehold spread is common when susceptible contacts are exposed.
Common presentationCatarrhal → paroxysmal → convalescentEarly symptoms are nonspecific; later cough can be distinctive but the “whoop” may be absent.
DiagnosisNasopharyngeal specimenPCR and culture are most useful when collected at the right time in illness.
TreatmentEarly macrolide antibioticsAntibiotics reduce transmission and help most when started early.
Key concernDTaP / Tdap + selected postexposure prophylaxisYoung infants can develop apnea, pneumonia, seizures and other severe complications.

Overview

Pertussis is a toxin-mediated infection of the respiratory tract caused by B. pertussis. The bacteria attach to ciliated airway cells and disrupt normal mucociliary clearance, producing a cough that can persist for many weeks even after the organism has been cleared. [1] [2]

The illness evolves in stages. During the early catarrhal stage, symptoms resemble a common cold and bacterial load is high. The paroxysmal stage brings bursts of rapid coughs, post-tussive vomiting and sometimes an inspiratory whoop. The convalescent stage is a slow decline in cough frequency and severity. [1] [2]

Vaccinated people can still develop pertussis because immunity wanes, but disease is often less severe. Infants—especially those too young to have completed primary vaccination—have the highest complication risk, which is why vaccination during every pregnancy and rapid household response are central prevention strategies. [1] [2] [3]

Symptoms and warning signs

Early symptoms include runny nose, nasal congestion, mild cough and low-grade fever. One to two weeks later, repeated coughing fits may cause vomiting, exhaustion or a whooping sound. Adults and adolescents may have only a prolonged severe cough, while young infants may have apnea, cyanosis or feeding difficulty with little obvious cough. [1] [2]

Call emergency services for an infant with apnea, blue color, severe breathing difficulty, poor responsiveness or repeated episodes of choking during cough. Any young infant with suspected pertussis deserves prompt medical assessment because deterioration can be rapid. [1] [2]

SYMPTOM MATRIX

Pertussis changes from a “cold” into a prolonged cough syndrome

Infants may show apnea or cyanosis rather than a classic whoop.

Vaccine-preventable infection
Early stage
  • Runny nose
  • Mild cough
  • Low fever
  • Sneezing
Paroxysmal stage
  • Repeated coughing fits
  • Inspiratory whoop
  • Vomiting after coughing
  • Exhaustion
High-risk infant signs
  • Apnea
  • Blue or gray color
  • Feeding difficulty
  • Breathing distress or poor responsiveness

Severe pertussis in young infants often requires hospital monitoring.

Diagnosis

Clinicians suspect pertussis from the duration and pattern of cough, exposure history and age. A nasopharyngeal swab or aspirate is collected because throat or anterior-nasal specimens are less suitable. PCR provides rapid sensitive detection, while culture is slower but highly specific and useful for surveillance. [1] [2]

Timing matters. Culture performs best early in illness, while PCR remains useful for several weeks after cough onset but can become less informative late in the course or after prolonged antibiotics. Serology may be used in selected later presentations depending on local laboratory practice. [1] [2] [3]

Viral respiratory infections, Mycoplasma infection, asthma, reflux and other causes of prolonged cough can mimic pertussis. In infants, bronchiolitis and other infections can cause apnea. A normal chest examination does not exclude pertussis because the main pathology is often in the airways rather than lung parenchyma. [2] [3]

Diagnostic pathway

Test early and use the correct nasopharyngeal specimen

Clinical suspicion should drive treatment in high-risk situations rather than waiting for a late test result.

Respiratory testing
1Recognize cough stage and riskNote duration, paroxysms, vomiting, apnea and infant age.
2Collect nasopharyngeal sampleUse PCR and/or culture according to illness timing.
3Treat high-risk suspected disease promptlyDo not wait for results when the history is strong and consequences are high.
4Manage contactsIdentify household members and other people who may need prophylaxis or vaccination review.
Rapid diagnostic testPCRnasopharyngeal
Reference / surveillanceCulturebest early

A negative late test does not completely exclude pertussis when the cough pattern and exposure history are compelling.

Causes, risk factors and clinical context

Anyone without adequate immunity can be infected, but severe disease is concentrated in young infants. Household exposure, pregnancy, healthcare or childcare settings and close contact with a newborn increase the public-health importance of a case. [1] [2]

Cough can persist for weeks to months as damaged airway epithelium recovers. Paroxysms may recur temporarily with later respiratory infections. Antibiotics started after several weeks generally do not shorten established cough because bacterial toxins have already triggered airway injury. [1] [2] [3]

Complications and why the diagnosis matters

Infants can develop pneumonia, apnea, seizures, encephalopathy, dehydration and weight loss. Older children and adults may develop rib fractures, syncope, urinary leakage or hernias from forceful coughing, although life-threatening complications are much less common than in infants. [1] [2]

Most older children and adults recover fully, although the cough can be prolonged. Prognosis is more guarded in very young infants and in people with severe respiratory compromise; early recognition and supportive hospital care substantially reduce risk. [1] [2] [3]

Treatment and management

Macrolide antibiotics—commonly azithromycin, clarithromycin or erythromycin—are recommended for treatment, with trimethoprim-sulfamethoxazole as an alternative in selected older patients. Treatment during the first one to two weeks is most likely to lessen symptoms and also reduces transmission. [1] [2]

Infants may need hospital monitoring, oxygen, suctioning, feeding support and management of apnea. Cough suppressants generally have limited benefit. Hydration and avoidance of smoke or other airway irritants are practical supportive measures during the long convalescent period. [1] [2] [3]

Antibiotic selection depends on age, pregnancy, interactions and regional resistance. Very young infants require special prescribing considerations. Starting antibiotics late may still be appropriate for transmission control in selected patients, but families should understand that cough may persist despite successful bacterial eradication. [1] [2]

Treatment & care hub

Treat early, protect infants and manage close contacts

The timing of therapy determines how much it can change symptoms versus transmission.

Pertussis care
AntibioticsEarly is best

Use a recommended macrolide

Early treatment can reduce illness severity and infectiousness.

Infant careHigh risk

Monitor breathing and feeding

Apnea, pneumonia and dehydration can require inpatient support.

ContactsSelective PEP

Prevent severe secondary cases

CDC prioritizes household and high-risk contacts for prophylaxis.

VaccinationRoutine

Maintain DTaP/Tdap protection

Pregnancy vaccination helps protect newborns before their own series is complete.

CDC advises considering treatment before test results when clinical suspicion is high or the patient/contact is at high risk.

Follow-up, recovery and prevention

Persistent cough does not necessarily mean treatment failed. Follow-up focuses on breathing, feeding, weight, return to activity and complications. Infants and pregnant patients require closer follow-up, while public-health teams may monitor contacts and outbreak settings. [1] [2]

Routine DTaP and Tdap vaccination is the foundation of prevention. Tdap during each pregnancy provides transplacental antibodies to newborns. Respiratory hygiene, isolation during the infectious period and appropriate postexposure prophylaxis further reduce spread. [1] [2] [3]

Special situations and care pathway

Pregnant people in the third trimester and households with young infants receive special consideration because the main goal of PEP is preventing severe infant disease. Macrolide-resistant B. pertussis is uncommon in many settings but travel history can affect antibiotic choice. [1] [2] [3]

The pathway is clinical recognition, age/risk assessment, nasopharyngeal testing, prompt treatment when indicated, evaluation of close contacts and vaccination status, and supportive care through a prolonged cough recovery. [1] [2]

When to seek urgent medical care

Emergency assessment is needed for apnea, cyanosis, severe breathing difficulty, dehydration, seizure, markedly reduced responsiveness or a young infant with repeated coughing/choking spells. [1] [2]

Clinical context

Infants bear the greatest risk of severe pertussis

Vaccination and targeted postexposure prophylaxis are designed to protect the people most likely to be hospitalized.

CDC — Clinical Overview of Pertussis ↗
Typical incubation5–10 dayscan be as long as 21 days
Best treatment windowFirst 1–2 weeks
Highest severe-disease riskYoung infants
CDC 2025: Pertussis cough can take weeks to months to resolve even after bacterial infection is treated.

Common questions

Frequently asked questions

Reference content

Sources

  1. CDC — Clinical Overview of Pertussis
  2. CDC — Treatment of Pertussis
  3. CDC — Pertussis Vaccination Recommendations

This article is based on trusted medical sources and is awaiting clinician review. It is not a substitute for personalized medical advice.